Retraction Watch readers, we could still really use your help

Dear Retraction Watch readers:

We hope that you continue to enjoy Retraction Watch, and find it — and our database of retractions — useful. Maybe you’re a researcher who likes keeping up with developments in scientific integrity. Maybe you’re a reporter who has found a story idea in our database, or on the blog. Maybe you’re an ethics instructor who uses the site to find case studies. Or a publisher who uses our blog to screen authors who submit manuscripts — we know at least two who do.

Whether you fall into one of those categories or another, we need your help. Continue reading Retraction Watch readers, we could still really use your help

UK House of Commons committee wants to make sure “university investigations into research misconduct are handled appropriately”

As Retraction Watch readers may recall, the UK’s House of Commons Science and Technology Committee has been holding an inquiry into scientific misconduct for well over a year. During that inquiry, we submitted written evidence including some statistics about how the UK’s retraction rate compared to other countries, and our Ivan Oransky gave oral testimony late last year.

Today, the committee released a report of its findings, along with several recommendations. Among them are for all UK universities to “establish a national Research Integrity Committee to provide a means of verifying that university investigations into research misconduct are handled appropriately.”

Norman Lamb, chair of the committee, said in a statement:

While most universities publish an annual report on research integrity, six years from signing a Concordat which recommends doing so it is not yet consistent across the sector. It’s not a good look for the research community to be dragging its heels on this, particularly given research fraud can quite literally become a matter of life and death.

We asked C. K. Gunsalus, who serves as director of the National Center for Professional & Research Ethics and who has studied institutional integrity for decades, for her take on the report.

C. K. Gunsalus

The House of Commons Science and Technology Committee’s Research Integrity: Sixth Report of Session 2017-19 Report is both good news and bad news. The good news is that the report crisply lays out the importance of a number of important challenges to research integrity, not only in the UK, but for all research communities internationally: Continue reading UK House of Commons committee wants to make sure “university investigations into research misconduct are handled appropriately”

University of Liverpool reverses course, names researcher guilty of misconduct

Daniel Antoine

A few weeks ago, we received a press release that gave us pause: The University of Liverpool said it had found one of its researchers guilty of research misconduct — but did not say who, nor which papers might be involved.

Now, less than one month later, the university is naming the researcher, and identifying a paper that it has asked the journal to retract.

After we covered the opaque release, we received some tips that the scientist might be Daniel Antoine, who studies liver damage. Last week, Liverpool confirmed that Antoine is the researcher in question.

After he left Liverpool, Antoine took a position at the University of Edinburgh. However, the faculty page is now blank, and a spokesperson told Retraction Watch he is “no longer employed by the University”:

Continue reading University of Liverpool reverses course, names researcher guilty of misconduct

Three years after questions surfaced, PLOS ONE retracts paper about potential antibiotic

In April 2015, two high-profile chemistry bloggers — and their commenters — raised questions about a paper that had been published in PLOS ONE some 18 months earlier. More than three years later, the journal has now retracted the paper, with a notice that echoes the 2015 blog posts.

So what took so long? PLOS tells Retraction Watch: Continue reading Three years after questions surfaced, PLOS ONE retracts paper about potential antibiotic

Journals punished by high-profile indexing service cry foul, demand a recount

A group of editors of journals focused on the history of economics has gone public to urge Clarivate Analytics, which publishes a highly influential ranking of journals, to reconsider its decision to drop the titles from this year’s index.

Clarivate said it suppressed the titles because of apparent “citation stacking,” in which various editors agree to cite one another to boost their journals’ Impact Factors (JIFs). The metric is based on average rates of citation over a given period. As we noted in a June 26 post about the suppressions, suppressing titles Continue reading Journals punished by high-profile indexing service cry foul, demand a recount

Researchers pull Nature paper over first author’s objections

Researchers have retracted a 2015 Nature paper about the molecular underpinnings of immune function after discovering they could not replicate key parts of the results.

The first author, Wendy Huang — who started working as an assistant professor at the University of California, San Diego, only months after the paper appeared — did not sign the retraction letter, published last week. The research was conducted while Huang was working as a postdoctoral fellow at New York University, home of last author Dan Littman (also an investigator at the Howard Hughes Medical Institute).

What happened appears to be a case of “he said, she said:” Littman asked to retract the paper after his lab couldn’t reproduce it, and Huang insists the data remain correct, saying the process had been “unfair and done without due process:”

Continue reading Researchers pull Nature paper over first author’s objections

Weekend reads: “Ethics dumping;” getting scientists to admit mistakes; the problem with conference dinner chatter

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured a collection of reports of scientific misconduct investigations, the story of a researcher who thought his work was important enough to be published three times, and a look at what happened when Elsevier tried open peer review. Here’s what was happening elsewhere: Continue reading Weekend reads: “Ethics dumping;” getting scientists to admit mistakes; the problem with conference dinner chatter

“The final verdict:” Lancet retracts two papers by Macchiarini

Paolo Macchiarini

The Lancet chapter of the Paolo Macchiarini saga appears to finally be over.

In an editorial titled “The final verdict on Paolo Macchiarini: guilty of misconduct,” the editors of the journal announce that they are retracting two papers by the now-disgraced surgeon and colleagues “after receiving requests to do so from the new President of the Karolinska Institute (KI), Ole Petter Ottersen.” Late last month, Ottersen declared Macchiarini and six other researchers — including one of the whistleblowers in the case — guilty of misconduct.

The long story took many twists and turns — for instance, in September 2015, Lancet editors wrote an editorial with close to the opposite title: “Paolo Macchiarini is not guilty of scientific misconduct,” published after KI released the results of a previous investigation:   Continue reading “The final verdict:” Lancet retracts two papers by Macchiarini

An author says his work should be “widely heralded and promoted.” So he published it 3 times.

Barislav Momčilović thinks that iodine status is — after iron deficiency — the “main public health” issue in the world today. So when he figured out what he believed was the best way to test levels of the mineral, he was determined to get the message out.

A little too determined, perhaps: He published the same information three times. And one journal caught on.  Last week, Thyroid retracted “Hair Iodine for Human Iodine Status Assessment,” a 2014 paper that they say overlapped with two earlier works.

While publishing duplicate work is considered by some to be just a violation of restrictive publisher copyright agreements, the presence of such duplicates in the literature can bias systematic reviews and other attempts to describe the state of the evidence in a given field. In a retraction notice, Thyroid noted that this was a case of Continue reading An author says his work should be “widely heralded and promoted.” So he published it 3 times.

After probe, journal removes flag from four papers, corrects manipulated images

Last year, Journal of Cell Science added notices to four papers after a reader contacted the editors with some concerns about issues with the figures. Now, it’s replacing the previous editorial notices with corrections, which address duplicated images and data.

When the journal issued expressions of concern for four papers co-authored by José Ignacio Rodriguez-Crespo about the allegations (which had also been raised on PubPeer), it notified his institution, the Universidad Complutense de Madrid (UCM). The newly issued correction notices explain that UCM investigated the four papers, and the data support the results and conclusions. In two cases, the authors supplied the original data, and in the others, they replicated the experiments.

Rodriguez-Crespo declined to comment, saying only that the journal

Continue reading After probe, journal removes flag from four papers, corrects manipulated images